![Alan Hoberman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alan Hoberman
Directeur/Membre du Conseil chez
BIOXYTRAN, INC.
Fortune : 16 281 $ au 30/06/2026
Profil
Dr. Alan M.
Hoberman is an Independent Director at BioXyTran, Inc. and a President & Chief Executive Officer at Argus International, Inc. He is on the Board of Directors at BioXyTran, Inc. Dr. Hoberman was previously employed as an Independent Director by Boston Therapeutics, Inc., an Executive Director-Site Operations & Toxicology by Argus Research Laboratories, Inc., and an Independent Director by Oxygen Therapy, Inc. He also served on the board at BioXyTran, Inc. /Old/.
He received his undergraduate degree from Drexel University, a graduate degree from The University of Arkansas and a doctorate degree from Pacific Western University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BIOXYTRAN, INC. 0,96% | 14/11/2025 | 416 207 ( 0,96% ) | 10 821 $ | 30/06/2026 |
BIOXYTRAN, INC. 0,21% | 18/11/2025 | 210 000 ( 0,21% ) | 5 460 $ | 30/06/2026 |
Postes actifs de Alan Hoberman
| Sociétés | Poste | Début |
|---|---|---|
| BIOXYTRAN, INC. | Directeur/Membre du Conseil | 02/11/2018 |
Argus International, Inc.
 Argus International, Inc. Industrial MachineryProducer Manufacturing Manufactures and sells printed circuit boards and thin film coating equipment | Directeur Général | - |
Anciens postes connus de Alan Hoberman
| Sociétés | Poste | Fin |
|---|---|---|
Oxygen Therapy, Inc.
 Oxygen Therapy, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-necrosis drugs | Directeur/Membre du Conseil | 03/08/2018 |
| NANOMIX CORPORATION | Directeur/Membre du Conseil | 15/09/2016 |
Argus Research Laboratories, Inc. | Corporate Officer/Principal | 01/01/2013 |
BioXyTran, Inc. /Old/
 BioXyTran, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Directeur/Membre du Conseil | - |
Formation de Alan Hoberman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
6
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Drexel University
 Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Arkansas
 The University of Arkansas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pacific Western University
 Pacific Western University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Argus International, Inc.
Argus International, Inc. Industrial MachineryProducer Manufacturing Manufactures and sells printed circuit boards and thin film coating equipment | Producer Manufacturing |
Argus Research Laboratories, Inc. | |
Boston Therapeutics, Inc.
 Boston Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and commercializes pharmaceutical products | Health Technology |
Oxygen Therapy, Inc.
Oxygen Therapy, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-necrosis drugs | Health Technology |
BioXyTran, Inc. /Old/
BioXyTran, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
BioXyTran, Inc.
 BioXyTran, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that engages in the development, manufacture and commercialization of therapeutic drugs | Health Technology |
